PhD Scientific Days 2023
Budapest, 22-23 June 2023
Menu
Report about the event
SUPhD mobile app
Program
Abstracts by authors
Clinical Medicine - Posters J
10:30 – 10:35 Gyulay, Kata K
Radiofrequency Ablation Treatment of Papillary Thyroid Microcarcinoma in Hungary
10:36 – 10:41 Tóth-Szumutku, Fanni
Co-occuring Genetic Syndromes Modifing the Phenotype of 22q11.2 Microdeletion Syndrome
10:42 – 10:47 Trinh, Sarolta
Synchronous cerebral rSO2 and mean arterial pressure changes in neonates undergoing general anesthesia
10:48 – 10:53 Balog, Vera
Regional cerebral oxygenation changes during neonatal anesthesia
10:54 – 10:59 Nagy, Alexandra
A reduction in body mass index (BMI) is a potential predictor of functional progression in patients with pulmonary fibrosis associated with connective tissue disease.
11:00 – 11:05 Balázs, Csoma
Past acute exacerbations predict future relapses in patients with chronic hypercapnic COPD receiving long-term non-invasive ventilation
11:06 – 11:11 Tóth, Nóra Melinda
SARS-CoV2 Vaccination In Hungarian IPF Patients
11:12 – 11:17 Polivka, Lörinc
Waning of SARS-Cov-2 vaccine effectiveness against delta variant in COPD patients
11:18 – 11:23 Molnár, Adél
Proposal of novel risk prediction score for major adverse cardiovascular events in lupus nephritis
11:24 – 11:29 Gönczi, Lóránt
Declining trends of reoperations and disease behavior progression in Crohn’s disease over different therapeutic eras – a prospective population-based study from western Hungary between 1977–2020, data from the Veszprem cohort
11:30 – 11:35 Pálla, Sára
Retrospective study of primary localized cutaneous amyloidosis
11:36 – 11:41 Király, Zsófia
Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but not in Subacute Cutaneous Lupus Erythematosus
11:42 – 11:47 Kiss, Norbert
Dermoscopy-guided High-frequency Ultrasound Can Differentiate Aggressive Histological Subtypes of Basal Cell Carcinoma
11:48 – 11:53 Hon-Balla, Bernadett
The Role of Dermatologists in the Early Recognition of Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis